The US Department of Justice on Thursday announced a $122 million settlement from three pharmaceutical companies as part of their effort to combat health care fraud.
While not admitting liability, Jazz, Lundbeck and Alexion agreed to pay to settle allegations that they violated the False Claims Act by undercutting the co-pay model of Medicare and the Civilian Health and Medical Program (ChampVa).
© 2023 Lawyer Herald All rights reserved. Do not reproduce without permission.
Get the Most Popular Lawyerherald Stories in a Weekly Newsletter
Join the Discussion
